Chalid Ghadban

565 total citations
27 papers, 453 citations indexed

About

Chalid Ghadban is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Neurology. According to data from OpenAlex, Chalid Ghadban has authored 27 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 10 papers in Pharmacology and 10 papers in Neurology. Recurrent topics in Chalid Ghadban's work include Neuroscience and Neuropharmacology Research (10 papers), Cannabis and Cannabinoid Research (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Chalid Ghadban is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Cannabis and Cannabinoid Research (10 papers) and Neuroinflammation and Neurodegeneration Mechanisms (10 papers). Chalid Ghadban collaborates with scholars based in Germany, United States and Sweden. Chalid Ghadban's co-authors include Faramarz Dehghani, Horst‐Werner Korf, Marco Koch, Tim Hohmann, Urszula Grabiec, Nils P. Hailer, Fahim Ebrahimi, Constance Hobusch, Philipp Pieroh and Ken Mackie and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Experimental Neurology.

In The Last Decade

Chalid Ghadban

26 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chalid Ghadban Germany 14 222 143 111 87 50 27 453
Irene Benito‐Cuesta Spain 10 145 0.7× 114 0.8× 83 0.7× 121 1.4× 42 0.8× 13 394
Raquel Bajo‐Grañeras Spain 9 94 0.4× 244 1.7× 154 1.4× 149 1.7× 72 1.4× 12 492
Yanyou Pan China 12 156 0.7× 156 1.1× 69 0.6× 121 1.4× 197 3.9× 16 577
Irene Sánchez-Vera Spain 9 304 1.4× 296 2.1× 294 2.6× 210 2.4× 66 1.3× 9 914
Maryam Sardari Iran 14 63 0.3× 160 1.1× 147 1.3× 214 2.5× 77 1.5× 35 580
Misha M. Riley United States 8 121 0.5× 146 1.0× 118 1.1× 199 2.3× 56 1.1× 13 625
C.T. O'Shaughnessy United Kingdom 10 194 0.9× 239 1.7× 47 0.4× 201 2.3× 54 1.1× 17 572
Ashbeel Roy Canada 10 64 0.3× 102 0.7× 158 1.4× 318 3.7× 37 0.7× 14 524
Simona Di Lascio Italy 16 65 0.3× 78 0.5× 66 0.6× 350 4.0× 42 0.8× 27 647
Juan Zhao China 13 65 0.3× 156 1.1× 77 0.7× 182 2.1× 46 0.9× 48 503

Countries citing papers authored by Chalid Ghadban

Since Specialization
Citations

This map shows the geographic impact of Chalid Ghadban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chalid Ghadban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chalid Ghadban more than expected).

Fields of papers citing papers by Chalid Ghadban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chalid Ghadban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chalid Ghadban. The network helps show where Chalid Ghadban may publish in the future.

Co-authorship network of co-authors of Chalid Ghadban

This figure shows the co-authorship network connecting the top 25 collaborators of Chalid Ghadban. A scholar is included among the top collaborators of Chalid Ghadban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chalid Ghadban. Chalid Ghadban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hohmann, Tim, et al.. (2022). Microglia-Dependent and Independent Brain Cytoprotective Effects of Mycophenolate Mofetil During Neuronal Damage. Frontiers in Aging Neuroscience. 14. 863598–863598. 4 indexed citations
2.
Ghadban, Chalid, et al.. (2022). Interaction of Glia Cells with Glioblastoma and Melanoma Cells under the Influence of Phytocannabinoids. Cells. 11(1). 147–147. 5 indexed citations
3.
Ghadban, Chalid, et al.. (2022). Jamming Transitions in Astrocytes and Glioblastoma Are Induced by Cell Density and Tension. Cells. 12(1). 29–29. 4 indexed citations
4.
Ghadban, Chalid, et al.. (2022). Nimodipine Exerts Time-Dependent Neuroprotective Effect after Excitotoxical Damage in Organotypic Slice Cultures. International Journal of Molecular Sciences. 23(6). 3331–3331. 4 indexed citations
5.
Hohmann, Tim, et al.. (2019). On the influence of cannabinoids on cell morphology and motility of glioblastoma cells. PLoS ONE. 14(2). e0212037–e0212037. 17 indexed citations
6.
Hohmann, Tim, et al.. (2019). Opposite Effects of Neuroprotective Cannabinoids, Palmitoylethanolamide, and 2-Arachidonoylglycerol on Function and Morphology of Microglia. Frontiers in Neuroscience. 13. 1180–1180. 22 indexed citations
7.
Hohmann, Tim, et al.. (2019). Synthetic Cannabinoids Influence the Invasion of Glioblastoma Cell Lines in a Cell- and Receptor-Dependent Manner.. Cancers. 11(2). 161–161. 8 indexed citations
8.
Pieroh, Philipp, Daniel‐Christoph Wagner, Chalid Ghadban, Gerd Birkenmeier, & Faramarz Dehghani. (2017). Ethyl pyruvate does not require microglia for mediating neuroprotection after excitotoxic injury. CNS Neuroscience & Therapeutics. 23(10). 798–807. 1 indexed citations
9.
Pieroh, Philipp, Daniel‐Christoph Wagner, Beat Alessandri, et al.. (2017). Comparative Examination of Temporal Glyoxalase 1 Variations Following Perforant Pathway Transection, Excitotoxicity, and Controlled Cortical Impact Injury. Neurotoxicity Research. 33(2). 412–421. 2 indexed citations
10.
Hohmann, Tim, et al.. (2016). The influence of biomechanical properties and cannabinoids on tumor invasion. Cell Adhesion & Migration. 11(1). 54–67. 29 indexed citations
11.
Pieroh, Philipp, Marco Koch, Daniel‐Christoph Wagner, et al.. (2014). Temporal Dynamics of Glyoxalase 1 in Secondary Neuronal Injury. PLoS ONE. 9(2). e87364–e87364. 10 indexed citations
12.
Ebrahimi, Fahim, Marco Koch, Philipp Pieroh, et al.. (2012). Time dependent neuroprotection of mycophenolate mofetil: effects on temporal dynamics in glial proliferation, apoptosis, and scar formation. Journal of Neuroinflammation. 9(1). 89–89. 23 indexed citations
13.
Grabiec, Urszula, Marco Koch, Sonja Kallendrusch, et al.. (2011). The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects after excitotoxic neuronal damage via cannabinoid receptor 1 (CB1). Neuropharmacology. 62(4). 1797–1807. 20 indexed citations
14.
Koch, Marco, Alexander Benz, Erik Maronde, et al.. (2010). Palmitoylethanolamide Protects Dentate Gyrus Granule Cells via Peroxisome Proliferator-Activated Receptor-Alpha. Neurotoxicity Research. 19(2). 330–340. 38 indexed citations
16.
Dehghani, Faramarz, Mutlay Sayan, Chalid Ghadban, et al.. (2010). Inhibition of microglial and astrocytic inflammatory responses by the immunosuppressant mycophenolate mofetil. Neuropathology and Applied Neurobiology. 36(7). 598–611. 13 indexed citations
17.
Ebrahimi, Fahim, et al.. (2010). Analyses of neuronal damage in excitotoxically lesioned organotypic hippocampal slice cultures. Annals of Anatomy - Anatomischer Anzeiger. 192(4). 199–204. 14 indexed citations
19.
Hailer, Nils P., et al.. (2008). Successful inhibition of excitotoxic neuronal damage and microglial activation after delayed application of interleukin‐1 receptor antagonist. Journal of Neuroscience Research. 86(15). 3314–3321. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026